Skip to main content

Applied Therapeutics, Inc.

APLTDelisted Feb 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001697532

Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding Applied Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of APLT: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders9075−15
Shares106.0M88.1M−18.0M (−17.0%)
Value$51.8M$27.4M−$24.5M (−47.2%)

New holders (14)

Institutions that held Applied Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to APLT in Q2 2025
InstitutionSharesValue% of portfolio
Pathstone Holdings, LLC2,643,540$822.4K0.00%
Citadel Advisors LLC474,094$147.5K0.00%
Birchview Capital, LP280,000$87.1K0.09%
Jain Global LLC84,890$26.4K0.00%
HRT Financial LP55,215$17.0K0.00%
Roble, Belko & Company, Inc30,841$10.0K0.00%
Ieq Capital, LLC16,251$5.06K0.00%
Stratos Wealth Advisors, LLC12,105$3.77K0.00%
Squarepoint Ops LLC10,282$3.20K0.00%
Jump Financial, LLC10,122$3.15K0.00%
ExodusPoint Capital Management, LP10,457$3.00K0.00%
Baader Bank INC13,700$2.63K0.00%
Essential Partners LLC225$700.00%
True Wealth Design, LLC59$190.00%

Sold out (29)

Institutions that held Applied Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.